文献速递神经MR

多发性硬化高级MRI:2024 McDonald标准的影像生物标志物转化

Advanced MRI in Multiple Sclerosis: Clinical Translation of Imaging Biomarkers in the 2024 McDonald Criteria.
PubMed 文献 · Radiology · 2026-01-01

本综述总结多发性硬化(MS)高级MRI的最新进展,重点解读2024年McDonald标准修订版新增的影像生物标志物。文中阐述视神经正式成为空间多发第五个部位,以及中央静脉征和顺磁性环病变作为支持MS的关键证据。同时指出将这些标志物整合到临床实践所面临的局限与挑战。

要点

  • 视神经已被正式采纳为MS空间多发的第五个部位。
  • 中央静脉征和顺磁性环病变是支持MS诊断的关键影像证据。
  • 高级MRI标志物旨在提高MS诊断和预后判断的准确性。

核心结论

  • 2024年McDonald标准修订版正式将视神经纳入空间多发部位,并采纳中央静脉征和顺磁性环病变作为MS的关键支持证据。
  • 高级MRI技术通过更高对比分辨率、更定量化和生物学信息化的成像方法,有望改善MS的诊断与预后判断。

研究设计与样本

  • 本文为综述,总结MS高级MRI的最新进展,聚焦2024年McDonald标准修订版新增的影像生物标志物。

关键影像表现/征象

  • 视神经病变可作为MS空间多发的第五个部位。
  • 中央静脉征是支持MS诊断的影像征象。
  • 顺磁性环病变是支持MS诊断的影像征象。

诊断标准与关键数值

  • 2024年McDonald标准修订版将视神经正式采纳为空间多发的第五个部位。
  • 中央静脉征和顺磁性环病变被列为支持MS诊断的关键证据。

临床应用与阅片要点

  • 阅片时应关注视神经、中央静脉征和顺磁性环病变,以辅助MS的早期诊断。
  • 在报告中有意识地评估并记录中央静脉征和顺磁性环病变,可提高MS诊断证据强度。

局限性

  • 将这些标志物整合到临床实践中仍存在局限和挑战,涵盖学术机构和社区医疗环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

MRI continues to be the foundation of multiple sclerosis (MS) diagnosis and management. The latest innovations in technology have paved the way for earlier diagnosis, more informed treatment selection, better means of evaluating the disease course, and personalized therapeutic responses. This review summarizes the most recent developments in advanced MRI for MS, highlighting biomarkers that were newly added in the 2024 revisions of the McDonald criteria, describing the ongoing importance of established imaging measures, reviewing the applications of artificial intelligence in clinical practice, and suggesting future directions. Special emphasis is placed on the official adoption of the optic nerve as a fifth site of dissemination in space, as well as on the central vein sign and paramagnetic rim lesions as key supporting evidence in MS. Additionally, ongoing limitations and challenges in integrating these markers into clinical practice across both academic and community settings are identified. The overall goal is to improve diagnosis and prognostication in MS through imaging approaches that have higher contrast resolution and are more quantitative and biologically informed.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Michaelson, Buathong, Treaba, et al. Advanced MRI in Multiple Sclerosis: Clinical Translation of Imaging Biomarkers in the 2024 McDonald Criteria. Radiology. 2026. PMID: 42578789. doi:10.1148/radiol.252139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。